NASDAQ:BOLT

Bolt Biotherapeutics . Stock Dividends

Healthcare > Biotechnology

Buy BOLT

*Your capital is at risk

$4.63

-0.480 (-9.39%)

At Close: Jun 03, 2026

BOLT Dividends Insights

BOLT used to pay dividends quarterly. Last paid amount was $0.0900 at Oct 02, 2014. As of today, dividend yield (TTM) is 0%.

Dividend Score Premium

Avoid dividend cuts
with our Dividend Score
Start 7-Day Free Trial

AI Analysis of BOLT

AI-Powered Dividend Insights

Built on AI-powered analysis of yield strength, recent news, payout trends, and 10-year dividend growth consistency.

Dividend Yield Range

The Dividend Yield Range is the range of values in which a stock’s dividend yield has fluctuated within a specified period, often a year. It represents the variation between the highest and lowest dividend yields observed during that time frame.

AI Analysis of BOLT

AI-Powered Market Insights

New!

Dividend Analysis

Key Stats

Dividend Yield (TTM)	0%
Frequency	Quarterly
1Y Growth	0%
Payout Ratio	0
Amount Per Share	$0.0900
Bolt Biotherapeutics, Inc. has not yet announced its next dividend date. Last payment date was: Oct 02, 2014.

BOLT Dividend Payout History

To ensure a understanding of BOLT's dividend performance, consider examining the historical payout ratios and how they align with the company's earnings. Fluctuations in payout amounts may reflect changes in the company's dividend policy or earnings stability.

#	Declaration Date	Ex-Date	Pay Date	Amount	Yield
1	Aug 13, 2014	Aug 29, 2014	Oct 02, 2014	$0.0900	0%
2	Apr 24, 2014	Jun 10, 2014	Jul 09, 2014	$0.0900	0%
3	Jan 22, 2014	Mar 03, 2014	Apr 02, 2014	$0.0900	0%
4	Nov 27, 2013	Dec 30, 2013	Jan 15, 2014	$0.0900	0%
5	Aug 14, 2013	Sep 03, 2013	Oct 03, 2013	$0.0900	0%
6	Apr 24, 2013	Jun 03, 2013	Jul 05, 2013	$0.0700	0%
7	Jan 25, 2013	Mar 05, 2013	Apr 04, 2013	$0.0700	0%
8	Nov 21, 2012	Nov 30, 2012	Dec 18, 2012	$0.0700	0%
9	Aug 22, 2012	Sep 04, 2012	Oct 04, 2012	$0.0700	0%
10	Apr 26, 2012	Jun 04, 2012	Jul 06, 2012	$0.0500	0%

Requires Login

Dividend Sustainability

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Overall, the near-term dividend outlook remains unpromising.

DSS - Sustainability score

Low (50.00%)

DSGP - Growth potential

No dividend growth expected in the near future

FAQ

What factors can affect the amount of BOLT's dividend payments?

The amount of BOLT's dividends can fluctuate based on several factors, including the company's financial performance, earnings, cash flow, capital requirements, and overall market conditions. Changes in BOLT sector's trends, interest rate shifts, and the company's operational adjustments can also influence dividend decisions.

Can dividends from BOLT stock be automatically reinvested?

If BOLT offers a Dividend Reinvestment Plan (DRIP), shareholders may have the option to automatically reinvest dividends to purchase additional shares. Please check with your brokerage for the availability and details of such a plan. Here's an easy guide on how to buy BOLT stock.

How often does BOLT pay dividend?

Bolt Biotherapeutics, Inc. (BOLT) used to pay dividends quarterly. The most recent payout was on Oct 02, 2014.

How much does BOLT pays per share?

The last recorder (Aug 29, 2014) dividend per share was $0.0900.

What is BOLT dividend growth rate?

Over the last year, Bolt Biotherapeutics, Inc. has witnessed growth rate of 0% . Looking back over the past 3 years, this growth rate has been 0%. Furthermore, examining the past 5 years, Bolt Biotherapeutics, Inc. has maintained an average Dividends Per Share Growth Rate of 0%.

ABOUT BOLT BIOTHERAPEUTICS, INC.

Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; BDC-2034, a carcinoembryonic antigen program for col...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by